BIOXCEL THERAPEUTICS
0.6600
08-11月-24 13:23:52
15 分の遅延
株式
-0.0101
-1.51%
本日の幅
0.6530 - 0.6800
ISIN
N/A
ソース
NASDAQ
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
01 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Termination of Proposed Public Offering
13 2 2024 09:00:43 提供 Nasdaq GlobeNewswire
-
12 2 2024 07:14:31 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Proposed Public Offering
08 2 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today
12 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs
11 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on Dec. 12, 2023
30 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
06 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Third Quarter 2023 Financial Results on November 14, 2023
31 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
30 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
25 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
10 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
04 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
14 8 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Second Quarter 2023 Financial Results on August 14, 2023
31 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
29 6 2023 06:00:00 提供 Nasdaq GlobeNewswire